CellaVision

Adoption of profit and loss account and balance sheet and discharge from liability
The AGM resolved to adopt the profit and loss account and the balance sheet as well as the consolidated profit and loss account and the consolidated balance sheet for the financial year 2023. Furthermore, the members of the Board of Directors and the CEO were discharged from liability for the financial year 2023.

Allocation of profit
The AGM resolved, in accordance with the Board of Directors’ proposal, on a dividend of SEK 2.25 per share with record date on 7 May 2024. The dividend is expected to be paid by Euroclear Sweden AB on 13 May 2024.

Board of Directors and auditor
The AGM resolved, in accordance with the Nomination committee’s proposal, on re-election of Mikael Worning, Christer Fåhraeus, Stefan Wolf, Ann-Charlotte Jarleryd and Louise Armstrong-Denby as Board members. Mikael Worning was also re-elected as the Chairman of the Board of Directors. The AGM resolved on re-election of the audit firm KPMG AB as auditor.

Furthermore, the AGM resolved on remuneration to the Board of Directors, remuneration to the auditor and additional remuneration for work in the Board’s committees in accordance with the Nomination committee’s proposal.

Nomination committee for the next Annual General Meeting
The AGM resolved, in accordance with the Nomination committee’s proposal, that the principles for appointing the Nomination committee which were adopted at the AGM in 2020 shall apply also for the AGM to be held in 2025.

Remuneration report
The AGM approved the Board of Directors’ remuneration report for the financial year 2023.